← Eichor
Condition: Stage Ii Colon Cancer Ajcc V8 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Stage Ii Colon Cancer Ajcc V8

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
NA · 2 location(s) · University of California, San Francisco · NCT04221893Family Communications After Genetic Testing
NA · 276 location(s) · Alliance for Clinical Trials in Oncology · NCT07143487Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cance
NA · 13 location(s) · City of Hope Medical Center · NCT07125729CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With
Phase 2 · 1 location(s) · Northwestern University · NCT05733000Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial
NA · 29 location(s) · UMC Utrecht · NCT06434896Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative I
Phase 2 · 4 location(s) · Emory University · NCT07405476Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or
Phase 2 · 5 location(s) · Emory University · NCT07140679Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
Phase N/A · 10 location(s) · M.D. Anderson Cancer Center · NCT04739072Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER
Phase 2 · 1 location(s) · Baylor College of Medicine · NCT05870800Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
Phase 2 · 11 location(s) · City of Hope Medical Center · NCT07595874The Sagittarius Trial
Phase 3 · 26 location(s) · IFOM ETS - The AIRC Institute of Molecular Oncology · NCT06490536Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survi
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06746012CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II
Phase 3 · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT04120701Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access an
Phase 2 · 1 location(s) · Mayo Clinic · NCT06265285Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Phase N/A · 2 location(s) · University of Southern California · NCT07259304Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03819296Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors
NA · 1 location(s) · Fred Hutchinson Cancer Center · NCT05930496Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
NA · 2 location(s) · Fred Hutchinson Cancer Center · NCT06995924
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.